| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.07B | +11.6% |
| Gross profit | ¥0.01B | — |
| Operating income | ¥-0.02B | — |
| Net income | ¥-0.02B | — |
| Gross margin | 12.2% | Net margin -29.6% |
| Revenue Q/Q | -58.5% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.06B | 87.8% |
| R&D | ¥0.01B | 9.5% |
| SG&A | ¥0.03B | 38.4% |
| Tax & other | ¥-0.00B | -1.5% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
实朴检测 ・ 纽泰格 ・ 泓博医药 ・ 荣信文化 ・ 飞沃科技 ・ 盛帮股份 ・ 五洲医疗 ・ 华康洁净 ・ 和顺科技 ・ 瑞泰新材 ・ 普瑞眼科 ・ 宏源药业
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies